Our patent insight reports focus on future and emerging technologies - in other words technical fields that have yet to reach a critical mass of patent applications. They are designed to provide valuable insights into these potentially disruptive technologies.
The methodology underlying these reports is free to use, meaning that anyone can apply our analytical approach to reveal trends and prospects in other future and emerging technologies.
For each report, we develop a search strategy, using unique attributes of EPO data such as classification (CPC), citations and patent families. The search strategy is then applied, optimising both recall and precision, to create a technology-specific dataset based on EPO data. The resulting reports act as "snapshots" of emerging technologies, taken in the light of patent data.
This study commissioned by the European Patent Office demonstrates the application of patent information to gain insights into specific technological fields, in this case Chimeric Antigen Receptor T-cell Immunotherapy (CAR T-cell Immunotherapy). A peer-reviewed paper was published in Nature Biotechnology and featured in a recent webinar.
This study conducted by the European Patent Office shows that the number of patent filings for second-generation quantum metrology and sensing devices is still small but has recently started to grow. It also reveals that a large proportion of the patent filings in this field come from academia, suggesting that researchers still account for most knowledge and exploitation of quantum physics.